Listed life-science companies
809 Nasdaq and NYSE companies, each with its pipeline, dated catalysts and recent results from its SEC filings.
#
- 3M Company MMM
- 4D Molecular Therapeutics, Inc. FDMT Phase 3 · ophthalmology
- 60 Degrees Pharmaceuticals, Inc. SXTP Phase 2 · infectious disease
A
- Aardvark Therapeutics, Inc. AARD Phase 3 · rare genetic
- AbbVie Inc. ABBV Phase 3 · immunology/inflammation
- AbCellera Biologics Inc. ABCL Phase 2 · endocrine/women's health
- Abeona Therapeutics Inc. ABEO Pre-clinical · rare genetic
- Abivax S.A. ABVX Phase 3 · GI/hepatology
- Absci Corp ABSI Phase 1 · dermatology
- Abvc Biopharma, Inc. ABVC Phase 2 · CNS/neurology/psychiatry
- AC Immune SA ACIU Phase 2 · CNS/neurology/psychiatry
- Acadia Pharmaceuticals Inc ACAD Phase 3 · CNS/neurology/psychiatry
- Accuray Inc ARAY oncology
- Achieve Life Sciences, Inc. ACHV Phase 3 · CNS/neurology/psychiatry
- Aclarion, Inc. ACON pain/anesthesia
- Aclaris Therapeutics, Inc. ACRS Phase 2 · immunology/inflammation
- Acrivon Therapeutics, Inc. ACRV Phase 2 · oncology
- Actinium Pharmaceuticals, Inc. ATNM Phase 1 · oncology
- Actuate Therapeutics, Inc. ACTU Phase 2 · oncology
- Acumen Pharmaceuticals, Inc. ABOS Phase 2 · CNS/neurology/psychiatry
- Acurx Pharmaceuticals, Inc. ACXP Phase 2 · infectious disease
- Adagene Inc. ADAG Phase 2 · oncology
- Adagio Medical Holdings, Inc. ADGM cardio-renal-metabolic
- Adaptive Biotechnologies Corp ADPT Pre-clinical · oncology
- ADARx Pharmaceuticals, Inc. ADRX Phase 3 · rare genetic
- ADC Therapeutics SA ADCT Phase 3 · oncology
- Addex Therapeutics Ltd. ADXN Pre-clinical · CNS/neurology/psychiatry
- Adial Pharmaceuticals, Inc. ADIL Pre-clinical · GI/hepatology
- Adicet Bio, Inc. ACET Phase 1 · immunology/inflammation
- Adlai Nortye Group Ltd. ANL Phase 1 · oncology
- Adma Biologics, Inc. ADMA Pre-clinical · immunology/inflammation
- Advanced Biomed Inc. ADVB
- AEON Biopharma, Inc. AEON Pre-clinical · CNS/neurology/psychiatry
- Aethlon Medical Inc AEMD oncology
- Agenus Inc AGEN Phase 2 · oncology
- Agios Pharmaceuticals, Inc. AGIO Phase 3 · hematology
- AgomAb Therapeutics AGMB Phase 2 · GI/hepatology
- AIM ImmunoTech Inc. AIM Phase 2 · oncology
- Akari Therapeutics Plc AKTX Pre-clinical · oncology
- Akebia Therapeutics, Inc. AKBA Phase 2 · cardio-renal-metabolic
- Aktis Oncology, Inc. AKTS Phase 1 · oncology
- Alaunos Therapeutics, Inc. TCRT Pre-clinical · cardio-renal-metabolic
- Aldeyra Therapeutics, Inc. ALDX Phase 3 · ophthalmology
- Alector, Inc. ALEC Pre-clinical · CNS/neurology/psychiatry
- Aligos Therapeutics, Inc. ALGS Phase 2 · infectious disease
- Alkermes plc ALKS Phase 3 · CNS/neurology/psychiatry
- Allarity Therapeutics, Inc. ALLR Phase 2 · oncology
- Allogene Therapeutics, Inc. ALLO Phase 2 · oncology
- Alnylam Pharmaceuticals, Inc. ALNY Phase 3 · rare genetic
- Alpha Cognition Inc. ACOG Pre-clinical · CNS/neurology/psychiatry
- Alpha Tau Medical Ltd. DRTS oncology
- Alphatec Holdings, Inc. ATEC other
- Alterity Therapeutics Ltd ATHE Phase 2 · CNS/neurology/psychiatry
- Altimmune, Inc. ALT Phase 3 · GI/hepatology
- Alto Neuroscience, Inc. ANRO Phase 2 · CNS/neurology/psychiatry
- Alumis Inc. ALMS Phase 3 · immunology/inflammation
- Alvotech ALVO Approved · immunology/inflammation
- ALX Oncology Holdings Inc. ALXO Phase 2 · oncology
- Alzamend Neuro, Inc. ALZN Phase 2 · CNS/neurology/psychiatry
- Amarin Corp Plc\uk AMRN Approved · cardio-renal-metabolic
- American Shared Hospital Services AMS
- Amgen Inc AMGN Approved · cardio-renal-metabolic
- Amneal Pharmaceuticals, Inc. AMRX Approved · CNS/neurology/psychiatry
- Amphastar Pharmaceuticals, Inc. AMPH Phase 3 · cardio-renal-metabolic
- Amylyx Pharmaceuticals, Inc. AMLX Phase 3 · endocrine/women's health
- AN2 Therapeutics, Inc. ANTX Phase 2 · infectious disease
- AnaptysBio, Inc. ANAB oncology
- Anavex Life Sciences Corp. AVXL Phase 1 · CNS/neurology/psychiatry
- AngioDynamics, Inc. ANGO Approved
- ANI Pharmaceuticals Inc ANIP Approved · immunology/inflammation
- Anika Therapeutics, Inc. ANIK Phase 3 · other
- Anixa Biosciences Inc ANIX Phase 1 · oncology
- Annexon, Inc. ANNX Phase 3 · CNS/neurology/psychiatry
- Annovis Bio, Inc. ANVS Phase 3 · CNS/neurology/psychiatry
- Apimeds Pharmaceuticals US, Inc. APUS Phase 2 · pain/anesthesia
- Apnimed, Inc. APMD Phase 3 · respiratory
- Apollomics Inc. APLM Phase 2 · oncology
- Aprea Therapeutics, Inc. APRE Phase 1 · oncology
- Aptevo Therapeutics Inc. APVO Phase 1 · oncology
- Apyx Medical Corp APYX other
- Aquestive Therapeutics, Inc. AQST Phase 3 · immunology/inflammation
- Arbutus Biopharma Corp ABUS Phase 2 · infectious disease
- Arcturus Therapeutics Holdings Inc. ARCT Phase 2 · rare genetic
- Arcus Biosciences, Inc. RCUS Phase 3 · oncology
- Arcutis Biotherapeutics, Inc. ARQT Phase 1 · dermatology
- Ardelyx, Inc. ARDX Phase 3 · GI/hepatology
- Argenx SE ARGX Phase 3 · immunology/inflammation
- Armata Pharmaceuticals, Inc. ARMP Phase 2 · infectious disease
- ArriVent BioPharma, Inc. AVBP Phase 3 · oncology
- Arrowhead Pharmaceuticals, Inc. ARWR Phase 3 · cardio-renal-metabolic
- ARS Pharmaceuticals, Inc. SPRY Phase 2 · immunology/inflammation
- Artelo Biosciences, Inc. ARTL Phase 2 · oncology
- Artiva Biotherapeutics, Inc. ARTV Phase 2 · immunology/inflammation
- Artivion, Inc. AORT cardio-renal-metabolic
- Arvinas, Inc. ARVN Phase 1 · oncology
- Ascendis Pharma A/S ASND Phase 3 · rare genetic
- Ascentage Pharma Group International AAPG Phase 3 · oncology
- Aspire-Lakewood Holdings, Inc. ASBP Phase 1 · cardio-renal-metabolic
- Assembly Biosciences, Inc. ASMB Phase 1 · infectious disease
- Astrazeneca PLC AZN Phase 3 · oncology
- Atara Biotherapeutics, Inc. ATRA Phase 3 · oncology
- Atea Pharmaceuticals, Inc. AVIR Phase 3 · infectious disease
- Atossa Therapeutics, Inc. ATOS Phase 2 · oncology
- AtriCure, Inc. ATRC cardio-renal-metabolic
- Atrium Therapeutics, Inc. RNA Pre-clinical · cardio-renal-metabolic
- Attovia Therapeutics, Inc. ATTO Phase 1 · immunology/inflammation
- aTyr Pharma, Inc. ATYR Phase 2 · respiratory
- Aura Biosciences, Inc. AURA Phase 3 · oncology
- Aurinia Pharmaceuticals Inc. AUPH Phase 1 · immunology/inflammation
- Aurora Cannabis Inc ACB
- Autolus Therapeutics plc AUTL Phase 2 · oncology
- Autonomix Medical, Inc. AMIX pain/anesthesia
- Avalo Therapeutics, Inc. AVTX Phase 2 · immunology/inflammation
- Avalyn Pharma Inc. AVLN Phase 2 · respiratory
- AVITA Medical, Inc. RCEL other
- Axsome Therapeutics, Inc. AXSM Phase 3 · CNS/neurology/psychiatry
- Aytu Biopharma, Inc AYTU Approved · CNS/neurology/psychiatry
- Azitra, Inc. AZTR Phase 1 · dermatology
B
- Baird Medical Investment Holdings Ltd BDMD oncology
- Bausch Health Companies Inc. BHC Phase 3 · GI/hepatology
- Baxter International Inc BAX other
- Beam Therapeutics Inc. BEAM Phase 2 · hematology
- Becton Dickinson & Co BDX
- Belite Bio, Inc BLTE Phase 3 · ophthalmology
- Benitec Biopharma Inc. BNTC Phase 2 · rare genetic
- BeOne Medicines Ltd. ONC Phase 3 · oncology
- Beta Bionics, Inc. BBNX endocrine/women's health
- Beyond Air, Inc. XAIR Phase 1 · respiratory
- BeyondSpring Inc. BYSI Phase 3 · oncology
- Bicara Therapeutics Inc. BCAX Phase 3 · oncology
- Bicycle Therapeutics PLC BCYC Phase 2 · oncology
- BillionToOne, Inc. BLLN other
- bioAffinity Technologies, Inc. BIAF Pre-clinical · oncology
- BioAge Labs, Inc. BIOA Phase 2 · cardio-renal-metabolic
- BioCardia, Inc. BCDA Phase 3 · cardio-renal-metabolic
- Biocryst Pharmaceuticals Inc BCRX Phase 3 · immunology/inflammation
- Biodesix Inc BDSX oncology
- Biodexa Pharmaceuticals Plc BDRX Phase 3 · oncology
- Biofrontera Inc. BFRI Phase 3 · dermatology
- Biogen Inc. BIIB Phase 3 · CNS/neurology/psychiatry
- Biohaven Ltd. BHVN Phase 3 · CNS/neurology/psychiatry
- BioLineRx Ltd. BLRX Phase 2 · oncology
- Biomarin Pharmaceutical Inc BMRN Phase 3 · rare genetic
- Biomea Fusion, Inc. BMEA Phase 2 · cardio-renal-metabolic
- BioNexus Gene Lab Corp BGLC oncology
- BioNTech SE BNTX Phase 3 · oncology
- BioStem Technologies, Inc. BSEM other
- Bioventus Inc. BVS
- BioVie Inc. BIVI Phase 2 · CNS/neurology/psychiatry
- Black Diamond Therapeutics, Inc. BDTX Phase 2 · oncology
- Bluejay Diagnostics, Inc. BJDX infectious disease
- Bolt Biotherapeutics, Inc. BOLT Phase 1 · oncology
- Boston Scientific Corp BSX
- Boundless Bio, Inc. BOLD Pre-clinical · oncology
- Brainsway Ltd. BWAY CNS/neurology/psychiatry
- Braveheart Bio, Inc. BRVE Phase 3 · cardio-renal-metabolic
- BriaCell Therapeutics Corp. BCTX Phase 3 · oncology
- BridgeBio Oncology Therapeutics, Inc. BBOT Phase 1 · oncology
- BridgeBio Pharma, Inc. BBIO Phase 3 · cardio-renal-metabolic
- Bright Minds Biosciences Inc. DRUG Phase 2 · CNS/neurology/psychiatry
- Bristol Myers Squibb Co BMY Phase 3 · oncology
- BullFrog AI Holdings, Inc. BFRG Pre-clinical · other
- Burning Rock Biotech Ltd BNR oncology
C
- C4 Therapeutics, Inc. CCCC Phase 2 · oncology
- Cabaletta Bio, Inc. CABA Phase 2 · immunology/inflammation
- Cadrenal Therapeutics, Inc. CVKD Phase 2 · hematology
- CalciMedica, Inc. CALC Phase 2 · GI/hepatology
- Calidi Biotherapeutics, Inc. CLDI Phase 1 · oncology
- Camp4 Therapeutics Corp CAMP Pre-clinical · CNS/neurology/psychiatry
- Can-Fite BioPharma Ltd. CANF Phase 3 · oncology
- Candel Therapeutics, Inc. CADL Phase 3 · oncology
- Canopy Growth Corp CGC other
- Capricor Therapeutics, Inc. CAPR Phase 3 · rare genetic
- Cardiff Oncology, Inc. CRDF Phase 2 · oncology
- Cardio Diagnostics Holdings, Inc. CDIO
- Cardiol Therapeutics Inc. CRDL Phase 3 · cardio-renal-metabolic
- Caribou Biosciences, Inc. CRBU Phase 1 · oncology
- Caris Life Sciences, Inc. CAI oncology
- Carlsmed, Inc. CARL
- Cartesian Therapeutics, Inc. RNAC Phase 3 · CNS/neurology/psychiatry
- Castle Biosciences Inc CSTL oncology
- CDT Equity Inc. CDT Pre-clinical · immunology/inflammation
- CEL-SCI Corp CVM Phase 3 · oncology
- Celcuity Inc. CELC Phase 3 · oncology
- Celldex Therapeutics, Inc. CLDX Phase 3 · immunology/inflammation
- Cellectar Biosciences, Inc. CLRB Phase 2 · oncology
- Cellectis S.A. CLLS Pre-clinical · cardio-renal-metabolic
- Celularity Inc CELU Phase 2 · other
- Century Therapeutics, Inc. IPSC Phase 1 · immunology/inflammation
- Cerenome, Inc. CNSY Phase 2 · oncology
- Cerus Corp CERS hematology
- CervoMed Inc. CRVO Phase 2 · CNS/neurology/psychiatry
- CG Oncology, Inc. CGON Phase 3 · oncology
- Chemomab Therapeutics Ltd. CMMB Phase 2 · GI/hepatology
- China Pharma Holding Inc. CPHI Approved
- China SXT Pharmaceuticals, Inc. SXTC other
- Cingulate Inc. CING Phase 3 · CNS/neurology/psychiatry
- Citius Oncology, Inc. CTOR Approved · oncology
- Citius Pharmaceuticals, Inc. CTXR Phase 3 · oncology
- City Therapeutics, Inc. CTY Phase 1 · hematology
- Clearmind Medicine Inc. CMND Phase 1 · CNS/neurology/psychiatry
- ClearPoint Neuro, Inc. CLPT CNS/neurology/psychiatry
- Clene Inc. CLNN Phase 2 · CNS/neurology/psychiatry
- Climb Bio, Inc. CLYM Phase 2 · cardio-renal-metabolic
- Clinuvel Pharmaceuticals Ltd CUVL Phase 2 · dermatology
- CNS Pharmaceuticals, Inc. CNSP Phase 2 · oncology
- Co-Diagnostics, Inc. CODX infectious disease
- Cocrystal Pharma, Inc. COCP Phase 1 · infectious disease
- Cogent Biosciences, Inc. COGT Phase 3 · oncology
- Cognition Therapeutics Inc CGTX Phase 2 · CNS/neurology/psychiatry
- Coherus Oncology, Inc. CHRS Phase 2 · oncology
- Collegium Pharmaceutical, Inc COLL Approved · pain/anesthesia
- COMPASS Pathways plc CMPS Phase 3 · CNS/neurology/psychiatry
- Compass Therapeutics, Inc. CMPX Phase 3 · oncology
- Compugen Ltd CGEN Phase 1 · oncology
- Connect Biopharma Holdings Ltd CNTB Phase 2 · respiratory
- Context Therapeutics Inc. CNTX Phase 1 · oncology
- Contineum Therapeutics, Inc. CTNM Phase 2 · respiratory
- Corbus Pharmaceuticals Holdings, Inc. CRBP Phase 2 · oncology
- Corcept Therapeutics Inc CORT Phase 3 · endocrine/women's health
- CorMedix Inc. CRMD Phase 3 · infectious disease
- Corvus Pharmaceuticals, Inc. CRVS Phase 3 · oncology
- Coya Therapeutics, Inc. COYA Phase 2 · CNS/neurology/psychiatry
- Creative Medical Technology Holdings, Inc. CELZ Phase 1 · pain/anesthesia
- Crescent Biopharma, Inc. CBIO Phase 1 · oncology
- CRISPR Therapeutics AG CRSP Phase 2 · hematology
- Cronos Group Inc. CRON
- Cue Biopharma, Inc. CUE Phase 2 · immunology/inflammation
- Cullinan Therapeutics, Inc. CGEM Phase 3 · oncology
- Cumberland Pharmaceuticals Inc CPIX Phase 2 · rare genetic
- Curanex Pharmaceuticals Inc CURX Pre-clinical · GI/hepatology
- Curis, Inc. CRIS Phase 2 · oncology
- CVRx, Inc. CVRX cardio-renal-metabolic
- Cypherpunk Technologies Inc. CYPH Phase 2 · oncology
- Cytokinetics Inc CYTK Phase 3 · cardio-renal-metabolic
- CytoMed Therapeutics Ltd GDTC Phase 1 · oncology
- CytomX Therapeutics, Inc. CTMX Phase 1 · oncology
- Cytosorbents Corp CTSO cardio-renal-metabolic
D
- Damora Therapeutics, Inc. DMRA Phase 1 · hematology
- Dare Bioscience, Inc. DARE Phase 3 · endocrine/women's health
- DarioHealth Corp. DRIO cardio-renal-metabolic
- DBV Technologies S.A. DBVT Phase 3 · immunology/inflammation
- Decoy Therapeutics Inc. DCOY Pre-clinical · infectious disease
- Definium Therapeutics, Inc. DFTX Phase 3 · CNS/neurology/psychiatry
- Delcath Systems, Inc. DCTH Phase 2 · oncology
- Denali Therapeutics Inc. DNLI Phase 2 · rare genetic
- Design Therapeutics, Inc. DSGN Phase 2 · ophthalmology
- DexCom, Inc. DXCM cardio-renal-metabolic
- DiaMedica Therapeutics Inc. DMAC Phase 2 · CNS/neurology/psychiatry
- Dianthus Therapeutics, Inc. DNTH Phase 3 · immunology/inflammation
- Disc Medicine, Inc. IRON Phase 3 · hematology
- Dogwood Therapeutics, Inc. DWTX Phase 2 · pain/anesthesia
- Dr. Reddy's Laboratories Ltd RDY Phase 3 · other
- Dyadic International Inc DYAI Phase 1 · other
- Dyne Therapeutics, Inc. DYN Phase 3 · rare genetic
E
- Edesa Biotech, Inc. EDSA Phase 3 · respiratory
- Edgewise Therapeutics, Inc. EWTX Phase 2 · cardio-renal-metabolic
- Editas Medicine, Inc. EDIT Pre-clinical · cardio-renal-metabolic
- Eikon Therapeutics, Inc. EIKN Phase 2 · oncology
- Elanco Animal Health Inc ELAN other
- Electra Therapeutics, Inc. ETRA Phase 2 · hematology
- Eledon Pharmaceuticals, Inc. ELDN Phase 2 · immunology/inflammation
- ELI LILLY & Co LLY Approved · cardio-renal-metabolic
- Elicio Therapeutics, Inc. ELTX Phase 2 · oncology
- Eloxx Pharmaceuticals, Inc. ELOX Phase 2 · rare genetic
- Embecta Corp. EMBC
- Emergent BioSolutions Inc. EBS Approved · infectious disease
- Enanta Pharmaceuticals, Inc. ENTA Phase 2 · infectious disease
- enGene Therapeutics Inc. ENGN Phase 2 · oncology
- Enliven Therapeutics, Inc. ELVN Phase 1 · oncology
- Enlivex Ltd. ENLV Phase 2 · immunology/inflammation
- Ensysce Biosciences, Inc. ENSC Phase 3 · pain/anesthesia
- Entera Bio Ltd. ENTX Phase 2 · endocrine/women's health
- Entrada Therapeutics, Inc. TRDA Phase 2 · rare genetic
- Enveric Biosciences, Inc. ENVB Pre-clinical · CNS/neurology/psychiatry
- enVVeno Medical Corp NVNO cardio-renal-metabolic
- Equillium, Inc. EQ Pre-clinical · GI/hepatology
- Erasca, Inc. ERAS Phase 1 · oncology
- Ernexa Therapeutics Inc. ERNA Pre-clinical · oncology
- Estrella Immunopharma, Inc. ESLA Phase 2 · oncology
- Eton Pharmaceuticals, Inc. ETON Phase 1 · endocrine/women's health
- Eupraxia Pharmaceuticals Inc. EPRX Phase 2 · GI/hepatology
- Evaxion A/S EVAX Phase 2 · oncology
- Evolus, Inc. EOLS Approved · dermatology
- Evommune, Inc. EVMN Phase 2 · immunology/inflammation
- Evotec SE EVO
- Exelixis, Inc. EXEL Phase 3 · oncology
- Exicure, Inc. XCUR Phase 2 · hematology
- Exozymes Inc. EXOZ Pre-clinical · other
F
- Faeth Therapeutics, Inc. FTH Phase 2 · oncology
- Fate Therapeutics Inc FATE Phase 1 · immunology/inflammation
- Femasys Inc FEMY endocrine/women's health
- Fennec Pharmaceuticals Inc. FENC Phase 3 · oncology
- FibroBiologics, Inc. FBLG Phase 1 · dermatology
- Filana Therapeutics, Inc. FLNA Pre-clinical · CNS/neurology/psychiatry
- First Tracks Biotherapeutics, Inc. TRAX Phase 2 · immunology/inflammation
- Flyte Aviation, Inc. VJET cardio-renal-metabolic
- Foghorn Therapeutics Inc. FHTX Phase 1 · oncology
- Fortrea Holdings Inc. FTRE
- Fortress Biotech, Inc. FBIO Phase 2 · dermatology
- Fractyl Health, Inc. GUTS Pre-clinical · cardio-renal-metabolic
- Freenome, Inc. FRNM oncology
- Fulcrum Therapeutics, Inc. FULC Pre-clinical
- Fulgent Genetics, Inc. FLGT Phase 2 · oncology
G
- Gain Therapeutics, Inc. GANX Phase 1 · CNS/neurology/psychiatry
- Galectin Therapeutics Inc GALT Phase 2 · GI/hepatology
- Galmed Pharmaceuticals Ltd. EOCN Phase 2 · oncology
- Genelux Corp GNLX Phase 3 · oncology
- Genenta Science S.p.A. GNTA Phase 1 · oncology
- Generate Biomedicines, Inc. GENB Phase 3 · respiratory
- Genmab A/S GMAB Phase 3 · oncology
- Genprex, Inc. GNPX Phase 2 · oncology
- GeoVax Labs, Inc. GOVX Phase 2 · oncology
- Geron Corporation GERN Phase 3 · hematology
- GH Research PLC GHRS Phase 2 · CNS/neurology/psychiatry
- Gilead Sciences, Inc. GILD Phase 3 · infectious disease
- Glass House Brands Inc. GLAS
- Glaukos Corporation GKOS Phase 3 · ophthalmology
- Globus Medical, Inc. GMED other
- Glucotrack, Inc. GCTK Phase 1 · cardio-renal-metabolic
- Gossamer Bio, Inc. GOSS Phase 3 · respiratory
- Grace Therapeutics, Inc. GRCE Phase 3 · CNS/neurology/psychiatry
- GRAIL, Inc. GRAL oncology
- Greenland Mines Ltd GRML Pre-clinical · CNS/neurology/psychiatry
- Greenwich LifeSciences, Inc. GLSI Phase 3 · oncology
- GRI Bio, Inc. GRI Phase 2 · respiratory
- Grifols SA GRFS Phase 3 · hematology
- GSK plc GSK Phase 3 · infectious disease
- GT Biopharma, Inc. GTBP Phase 1 · oncology
- Guardant Health, Inc. GH oncology
- Gyre Therapeutics, Inc. GYRE Phase 3 · GI/hepatology
H
- Haemonetics Corp HAE hematology
- Halozyme Therapeutics, Inc. HALO Approved · other
- Harmony Biosciences Holdings, Inc. HRMY Phase 3 · CNS/neurology/psychiatry
- Harrow, Inc. HROW Approved · ophthalmology
- HCW Biologics Inc. HCWB Phase 1 · immunology/inflammation
- HeartBeam, Inc. BEATW cardio-renal-metabolic
- Heartflow, Inc. HTFL cardio-renal-metabolic
- Helus Pharma Inc. HELP Phase 3 · CNS/neurology/psychiatry
- Hemab Therapeutics Holdings, Inc. COAG Phase 2 · hematology
- Heron Therapeutics, Inc. HRTX Pre-clinical · pain/anesthesia
- Humacyte, Inc. HUMA Phase 3 · cardio-renal-metabolic
- HUTCHMED (China) Ltd HCM Phase 3 · oncology
I
- Iambic Therapeutics, Inc. IAM Phase 1 · oncology
- iBio, Inc. IBIO Phase 1 · cardio-renal-metabolic
- IceCure Medical Ltd. ICCM oncology
- ICU Medical Inc ICUI
- IDEAYA Biosciences, Inc. IDYA Phase 3 · oncology
- IGC Pharma, Inc. IGC Phase 2 · CNS/neurology/psychiatry
- IM Cannabis Corp. IMCC
- ImageneBio, Inc. IMA Phase 2 · immunology/inflammation
- Immatics N.V. IMTX Phase 3 · oncology
- Immix Biopharma, Inc. IMMX Phase 2 · hematology
- Immucell Corp ICCC infectious disease
- Immunic, Inc. IMUX Phase 3 · CNS/neurology/psychiatry
- ImmunityBio, Inc. IBRX Phase 3 · oncology
- Immunocore Holdings plc IMCR Phase 3 · oncology
- Immunome Inc. IMNM Phase 3 · oncology
- Immunovant, Inc. IMVT Phase 3 · immunology/inflammation
- Immuron Ltd IMRN Phase 2 · infectious disease
- Immutep Limited IMMP Phase 2 · oncology
- Impact Biomedical Inc. IBO
- Imunon, Inc. IMNN Phase 3 · oncology
- IN8BIO, Inc. INAB Phase 1 · oncology
- Incyte Corp INCY Phase 3 · hematology
- Indaptus Therapeutics, Inc. INDP Pre-clinical · oncology
- Indivior Pharmaceuticals, Inc. INDV Approved · CNS/neurology/psychiatry
- InflaRx N.V. IFRX Phase 2 · immunology/inflammation
- InfuSystem Holdings, Inc INFU
- Inhibikase Therapeutics, Inc. IKT Phase 3 · respiratory
- Inhibrx Biosciences, Inc. INBX Phase 3 · oncology
- InMed Pharmaceuticals Inc. INM Pre-clinical · CNS/neurology/psychiatry
- Inmune Bio, Inc. INMB Phase 3 · rare genetic
- Innate Pharma SA IPHA Phase 2 · oncology
- Innoviva, Inc. INVA Approved · infectious disease
- Inovio Pharmaceuticals, Inc. INO Phase 3 · infectious disease
- Insight Molecular Diagnostics Inc. IMDX other
- Insmed Incorporated INSM Phase 3 · respiratory
- Inspire Medical Systems, Inc. INSP respiratory
- InspireMD, Inc. NSPR cardio-renal-metabolic
- Instil Bio, Inc. TIL (delisted) Pre-clinical
- Insulet Corp PODD cardio-renal-metabolic
- Integra LifeSciences Holdings Corporation IART
- Intellia Therapeutics, Inc. NTLA Phase 3 · rare genetic
- Intelligent Bio Solutions Inc. INBS
- Intensity Therapeutics, Inc. INTS Phase 3 · oncology
- Intercure Ltd. INCR
- Inventiva S.A. IVA Phase 3 · GI/hepatology
- Invivyd, Inc. IVVD Phase 3 · infectious disease
- INVO Fertility, Inc. IVF endocrine/women's health
- Ionis Pharmaceuticals Inc IONS Phase 3 · cardio-renal-metabolic
- Iovance Biotherapeutics, Inc. IOVA Phase 3 · oncology
- Iradimed Corp IRMD other
- iRhythm Holdings, Inc. IRTC cardio-renal-metabolic
- Ironwood Pharmaceuticals Inc IRWD Phase 3 · GI/hepatology
- IRulya Therapeutics Inc. IRLA Phase 2 · respiratory
J
- Jade Biosciences, Inc. JBIO Phase 2 · immunology/inflammation
- Jaguar Health, Inc. JAGX Phase 3 · GI/hepatology
- Janux Therapeutics, Inc. JANX Phase 1 · oncology
- Jasper Therapeutics, Inc. JSPR Phase 2 · cardio-renal-metabolic
- Jazz Pharmaceuticals plc JAZZ Approved · oncology
- Johnson & Johnson JNJ Approved
- Journey Medical Corp DERM Approved · dermatology
- Jupiter Neurosciences, Inc. JUNS Phase 2 · CNS/neurology/psychiatry
- Jyong Biotech Ltd. JYNG Phase 3 · other
K
- Kailera Therapeutics, Inc. KLRA Phase 3 · cardio-renal-metabolic
- Kairos Pharma, LTD. KAPA Phase 2 · oncology
- KALA BIO, Inc. KALA Phase 2 · ophthalmology
- Kalaris Therapeutics, Inc. KLRS Phase 1 · ophthalmology
- Kamada Ltd KMDA Phase 3 · infectious disease
- Kardigan, Inc. KARD Phase 3 · cardio-renal-metabolic
- Karyopharm Therapeutics Inc. KPTI Phase 3 · oncology
- Kazia Therapeutics Ltd KZIA Phase 2 · oncology
- Keros Therapeutics, Inc. KROS Phase 2 · CNS/neurology/psychiatry
- Kestra Medical Technologies, LTD. KMTS cardio-renal-metabolic
- Kiniksa Pharmaceuticals International, plc KNSA Phase 3 · immunology/inflammation
- Kiora Pharmaceuticals, Inc. KPRX Phase 2 · ophthalmology
- Kodiak Sciences Inc. KOD Phase 3 · ophthalmology
- Korro Bio, Inc. KRRO Pre-clinical · rare genetic
- Korsana Biosciences, Inc. KRSA Pre-clinical · CNS/neurology/psychiatry
- KORU Medical Systems, Inc. KRMD immunology/inflammation
- Krystal Biotech, Inc. KRYS Phase 3 · rare genetic
- Kura Oncology, Inc. KURA Phase 3 · oncology
- Kymera Therapeutics, Inc. KYMR Phase 2 · immunology/inflammation
- Kyntra Bio, Inc. KYNB Phase 2 · oncology
- Kyverna Therapeutics, Inc. KYTX Phase 3 · CNS/neurology/psychiatry
L
- Labcorp Holdings Inc. LH
- Lakefront Biotherapeutics LKFT Phase 2 · immunology/inflammation
- Lakewood-Amedex Biotherapeutics Inc. LABT Phase 2 · infectious disease
- Lantern Pharma Inc. LTRN Phase 2 · oncology
- Lantheus Holdings, Inc. LNTH Phase 3 · CNS/neurology/psychiatry
- Larimar Therapeutics, Inc. LRMR Phase 2 · rare genetic
- LB Pharmaceuticals Inc LBRX Phase 3 · CNS/neurology/psychiatry
- Legend Biotech Corp LEGN Pre-clinical · oncology
- LeMaitre Vascular, Inc. LMAT cardio-renal-metabolic
- LENSAR, Inc. LNSR ophthalmology
- LENZ Therapeutics, Inc. LENZ Approved · ophthalmology
- LeonaBio, Inc. LONA Phase 3 · oncology
- Lexaria Bioscience Corp. LEXX Phase 1 · cardio-renal-metabolic
- Lexeo Therapeutics, Inc. LXEO Phase 2 · cardio-renal-metabolic
- Lexicon Pharmaceuticals, Inc. LXRX Phase 3 · cardio-renal-metabolic
- Liminatus Pharma, Inc. LIMN Pre-clinical · oncology
- Lineage Cell Therapeutics, Inc. LCTX Phase 2 · ophthalmology
- Lipocine Inc. LPCN Phase 3 · CNS/neurology/psychiatry
- Liquidia Corp LQDA Phase 3 · respiratory
- Lisata Therapeutics, Inc. LSTA Phase 2 · oncology
- Longeveron Inc. LGVN Phase 2 · cardio-renal-metabolic
- Lucid Diagnostics Inc. LUCD GI/hepatology
- Lumexa Imaging Holdings, Inc. LMRI
- Lunai Bioworks Inc. LNAI Pre-clinical · oncology
- Lyell Immunopharma, Inc. LYEL Phase 3 · oncology
M
- Macrogenics Inc MGNX Phase 1 · oncology
- Madrigal Pharmaceuticals, Inc. MDGL Phase 3 · GI/hepatology
- MAIA Biotechnology, Inc. MAIA Phase 3 · oncology
- MannKind Corporation MNKD Phase 2 · cardio-renal-metabolic
- MapLight Therapeutics, Inc. MPLT Phase 2 · CNS/neurology/psychiatry
- Marker Therapeutics, Inc. MRKR Phase 1 · oncology
- Matinas BioPharma Holdings, Inc. MTNB Phase 2 · infectious disease
- MaxCyte, Inc. MXCT
- Maze Therapeutics, Inc. MAZE Phase 2 · cardio-renal-metabolic
- MBX Biosciences, Inc. MBX Phase 2 · endocrine/women's health
- MDxHealth SA MDXH oncology
- Medicinova Inc MNOV Phase 2 · CNS/neurology/psychiatry
- Medicus Pharma Ltd. MDCX Phase 2 · oncology
- MediWound Ltd. MDWD Phase 3 · dermatology
- Medline Inc. MDLN
- MeiraGTx Holdings plc MGTX Phase 3 · ophthalmology
- Merck & Co., Inc. MRK Phase 3 · oncology
- Mereo BioPharma Group plc MREO Phase 3 · rare genetic
- Merit Medical Systems Inc MMSI other
- Mesoblast Ltd MESO Phase 3 · pain/anesthesia
- Metagenomi Therapeutics, Inc. MGX Pre-clinical · hematology
- MetaVia Inc. MTVA Phase 2 · cardio-renal-metabolic
- Microbot Medical Inc. MBOT cardio-renal-metabolic
- Milestone Pharmaceuticals Inc. MIST Phase 2 · cardio-renal-metabolic
- MindWalk Holdings Corp. HYFT Pre-clinical · other
- Mineralys Therapeutics, Inc. MLYS Phase 3 · cardio-renal-metabolic
- Minerva Neurosciences, Inc. NERV Phase 3 · CNS/neurology/psychiatry
- MiniMed Group, Inc. MMED cardio-renal-metabolic
- MiNK Therapeutics, Inc. INKT Phase 2 · respiratory
- Mira Pharmaceuticals, Inc. MIRA Phase 1 · pain/anesthesia
- Mirum Pharmaceuticals, Inc. MIRM Phase 3 · GI/hepatology
- Mobia Medical, Inc. MOBI CNS/neurology/psychiatry
- Moderna, Inc. MRNA Phase 3 · infectious disease
- Modular Medical, Inc. MODD cardio-renal-metabolic
- Molecular Partners AG MOLN Phase 2 · oncology
- Moleculin Biotech, Inc. MBRX Phase 2 · oncology
- Monopar Therapeutics MNPR Phase 3 · rare genetic
- Monte Rosa Therapeutics, Inc. GLUE Phase 1 · immunology/inflammation
- MoonLake Immunotherapeutics MLTX Phase 3 · immunology/inflammation
- Mustang Bio, Inc. MBIO Phase 1 · oncology
N
- Nanobiotix S.A. NBTX Phase 3 · oncology
- Nanoviricides, Inc. NNVC Phase 1 · infectious disease
- Nasus Pharma Ltd NSRX Phase 2 · immunology/inflammation
- Natural Alternatives International, Inc. NAII
- Nektar Therapeutics NKTR Phase 3 · immunology/inflammation
- Neonc Technologies Holdings, Inc. NTHI Phase 2 · oncology
- Nephros Inc NEPH
- NervGen Pharma Corp. NGEN Phase 2 · CNS/neurology/psychiatry
- Neumora Therapeutics, Inc. NMRA Phase 1 · CNS/neurology/psychiatry
- Neuphoria Therapeutics Inc. NEUP Phase 2 · CNS/neurology/psychiatry
- Neurocrine Biosciences Inc NBIX Phase 3 · CNS/neurology/psychiatry
- Neurogene Inc. NGNE Phase 2 · CNS/neurology/psychiatry
- Neuronetics, Inc. STIM CNS/neurology/psychiatry
- NEUROONE MEDICAL TECHNOLOGIES Corp NMTC CNS/neurology/psychiatry
- NeuroPace Inc NPCE CNS/neurology/psychiatry
- NeuroSense Therapeutics Ltd. NRSN Phase 2 · CNS/neurology/psychiatry
- NewAmsterdam Pharma Company N.V. NAMS Phase 3 · cardio-renal-metabolic
- NewcelX Ltd. NCEL Pre-clinical · cardio-renal-metabolic
- Nexentis Technologies Ltd. NXTS Pre-clinical · oncology
- Nexgel, Inc. NXGL dermatology
- NextCure, Inc. NXTC Pre-clinical · oncology
- Niagen Bioscience, Inc. Unknown Pre-clinical · rare genetic
- Nkarta, Inc. NKTX Phase 2 · immunology/inflammation
- Nomad Power Solutions, Inc. NMAD Phase 1 · oncology
- Not specified Not specified Phase 2 · respiratory
- Not specified in extract Not specified in extract Phase 3 · pain/anesthesia
- Not stated in extract Not stated in extract
- NovaBridge Biosciences NBP Phase 2 · oncology
- Novartis AG NVS Phase 3 · cardio-renal-metabolic
- Novavax Inc NVAX Phase 3 · infectious disease
- Novo Nordisk A/S NVO Phase 3 · cardio-renal-metabolic
- NovoCure Ltd NVCR oncology
- NRx Pharmaceuticals, Inc. NRXP Phase 3 · CNS/neurology/psychiatry
- NuCana plc NCNA Phase 2 · oncology
- Nurix Therapeutics, Inc. NRIX Phase 3 · oncology
- Nuvation Bio Inc. NUVB Approved · oncology
- Nuvectis Pharma, Inc. NVCT Phase 3 · hematology
- Nyxoah SA NYXH
O
- Obsidian Therapeutics, Inc. OBX Phase 2 · oncology
- Ocugen, Inc. OCGN Phase 3 · ophthalmology
- Ocular Therapeutix, Inc. OCUL Phase 3 · ophthalmology
- Oculis Holding AG OCS Phase 3 · ophthalmology
- Odyssey Therapeutics, Inc. ODTX Phase 2 · immunology/inflammation
- OKYO Pharma Ltd OKYO Phase 3 · ophthalmology
- Olema Pharmaceuticals, Inc. OLMA Phase 3 · oncology
- Omeros Corp OMER Phase 1 · hematology
- Oncolytics Biotech Inc. ONCY Phase 2 · oncology
- Onconetix, Inc. ONCO oncology
- OnKure Therapeutics, Inc. OKUR Pre-clinical · oncology
- Opko Health, Inc. OPK Pre-clinical · cardio-renal-metabolic
- Optimi Health Corp. OPTH Phase 2 · CNS/neurology/psychiatry
- Opus Genetics, Inc. IRD Phase 3 · ophthalmology
- Oragenics Inc OGEN Phase 2 · CNS/neurology/psychiatry
- Oramed Pharmaceuticals Inc. ORMP Phase 3 · endocrine/women's health
- Orasure Technologies Inc OSUR infectious disease
- Orchestra BioMed Holdings, Inc. OBIO cardio-renal-metabolic
- Organigram Global Inc. OGI
- Organogenesis Holdings Inc. ORGO Phase 3 · dermatology
- Organon & Co. OGN Phase 3 · endocrine/women's health
- Oric Pharmaceuticals, Inc. ORIC Phase 3 · oncology
- Orthofix Medical Inc. OFIX other
- Orthopediatrics Corp KIDS other
- Oruka Therapeutics, Inc. ORKA Phase 2 · dermatology
- OS Therapies Inc OSTX Phase 2 · oncology
- Outlook Therapeutics, Inc. OTLK Approved · ophthalmology
- Ovid Therapeutics Inc. OVID Phase 2 · CNS/neurology/psychiatry
P
- Pacira BioSciences, Inc. PCRX Phase 2 · pain/anesthesia
- Palatin Technologies, Inc. PTN Pre-clinical · endocrine/women's health
- Palisade Bio, Inc. PALI Phase 1 · GI/hepatology
- Palvella Therapeutics, Inc. PVLA Phase 3 · dermatology
- Parabilis Medicines, Inc. PBLS Phase 1 · oncology
- Pasithea Therapeutics Corp. KTTA Phase 1 · oncology
- PAVmed Inc. PAVM GI/hepatology
- PDS Biotechnology Corp PDSB Phase 2 · oncology
- Pelthos Therapeutics Inc. PTHS Phase 2 · dermatology
- Penumbra Inc PEN cardio-renal-metabolic
- PepGen Inc. PEPG Phase 2 · rare genetic
- Personalis, Inc. PSNL oncology
- Perspective Therapeutics, Inc. CATX Phase 1 · oncology
- Pfizer Inc PFE Phase 3 · other
- PharmaCyte Biotech, Inc. PMCB Pre-clinical · oncology
- Pharming Group N.V. PHAR Phase 3 · immunology/inflammation
- Pharvaris N.V. PHVS Phase 3 · rare genetic
- Phathom Pharmaceuticals, Inc. PHAT Phase 2 · GI/hepatology
- Phio Pharmaceuticals Corp. PHIO Phase 1 · oncology
- Picard Medical, Inc. PMI cardio-renal-metabolic
- Pliant Therapeutics, Inc. PLRX Phase 1 · oncology
- Pluri Inc. PLUR Pre-clinical · other
- PMGC Holdings Inc. ELAB Phase 1 · cardio-renal-metabolic
- PMV Pharmaceuticals, Inc. PMVP Phase 2 · oncology
- Polaryx Therapeutics, Inc. PLYX Phase 2 · rare genetic
- PolyPid Ltd. PYPD Phase 3 · infectious disease
- Polyrizon Ltd. PLRZ Pre-clinical · respiratory
- Praxis Precision Medicines, Inc. PRAX Phase 3 · CNS/neurology/psychiatry
- Precigen, Inc. PGEN Phase 2 · respiratory
- Precision BioSciences, Inc. DTIL Phase 1 · infectious disease
- Prelude Therapeutics Inc PRLD Phase 1 · oncology
- Prestige Consumer Healthcare Inc. PBH
- PRF Technologies Ltd. PRFX Phase 1 · ophthalmology
- Prime Medicine, Inc. PRME Phase 1 · rare genetic
- PRO DEX Inc PDEX other
- PROCEPT BioRobotics Corp PRCT
- Processa Pharmaceuticals, Inc. PCSA Phase 1 · immunology/inflammation
- Profound Medical Corp. PROF
- Profusa, Inc. PFSA cardio-renal-metabolic
- Prokidney Corp. PROK Phase 3 · cardio-renal-metabolic
- ProMIS Neurosciences Inc. PMN Phase 1 · CNS/neurology/psychiatry
- Propanc Biopharma, Inc. PPCB Pre-clinical · oncology
- ProQR Therapeutics N.V. PRQR Phase 1 · GI/hepatology
- Protagonist Therapeutics, Inc PTGX Phase 1 · immunology/inflammation
- Protalix BioTherapeutics, Inc. PLX Phase 2 · rare genetic
- Protara Therapeutics, Inc. TARA Phase 2 · oncology
- Prothena Corp Public Ltd Co PRTA Phase 1 · CNS/neurology/psychiatry
- Psyence Biomedical Ltd. PBM Phase 2 · CNS/neurology/psychiatry
- PTC Therapeutics, Inc. PTCT Phase 3 · rare genetic
- Pulmatrix, Inc. PULM Phase 1 · CNS/neurology/psychiatry
- Pulmonx Corp LUNG respiratory
- Pulse Biosciences, Inc. PLSE cardio-renal-metabolic
- Pulsenmore Ltd. PLSM endocrine/women's health
- Puma Biotechnology, Inc. PBYI Phase 2 · oncology
- Purple Biotech LTD. PPBT Phase 2 · oncology
- Pyxis Oncology, Inc. PYXS Phase 1 · oncology
Q
- Q32 Bio Inc. QTTB Phase 2 · immunology/inflammation
- QTREX Quantum Ltd. QTEX respiratory
- Quantum BioPharma Ltd. QNTM Phase 1 · CNS/neurology/psychiatry
- Quantum Cyber Inc. QUCY other
- Quest Diagnostics Incorporated DGX
- Quoin Pharmaceuticals Ltd. QNRX Phase 2 · dermatology
R
- Radiopharm Theranostics Ltd RADX Phase 2 · oncology
- RadNet, Inc. RDNT
- Rafael Holdings, Inc. RFL Phase 3 · rare genetic
- Rallybio Corp RLYB Phase 1 · hematology
- Rani Therapeutics Holdings, Inc. RANI Phase 1 · cardio-renal-metabolic
- Rapport Therapeutics, Inc. RAPP Phase 3 · CNS/neurology/psychiatry
- Recursion Pharmaceuticals, Inc. RXRX Phase 2 · rare genetic
- RedHill Biopharma Ltd. RDHL Phase 2 · GI/hepatology
- Regencell Bioscience Holdings Limited RGC Pre-clinical · CNS/neurology/psychiatry
- Regeneron Pharmaceuticals, Inc. REGN Phase 3 · ophthalmology
- REGENXBIO Inc. RGNX Phase 3 · rare genetic
- Rein Therapeutics, Inc. RNTX Phase 2 · respiratory
- Relay Therapeutics, Inc. RLAY Phase 3 · oncology
- Relmada Therapeutics, Inc. RLMD Phase 2 · oncology
- RenovoRx, Inc. RNXT Phase 3 · oncology
- Replimune Group, Inc. REPL Phase 3 · oncology
- Resmed Inc RMD respiratory
- Retension Pharmaceuticals, Inc. RTSN Phase 2 · cardio-renal-metabolic
- Retractable Technologies, Inc. RVP other
- Revelation Biosciences, Inc. REVB Phase 1 · cardio-renal-metabolic
- Revolution Medicines, Inc. RVMD Phase 3 · oncology
- Rezolute, Inc. RZLT Phase 3 · endocrine/women's health
- Rhythm Pharmaceuticals, Inc. RYTM Phase 3 · endocrine/women's health
- Rigel Pharmaceuticals Inc RIGL Phase 2 · hematology
- Rocket One Inc. RKTO Phase 2 · dermatology
- Rocket Pharmaceuticals, Inc. RCKT Phase 2 · rare genetic
- Rockwell Medical, Inc. RMTI cardio-renal-metabolic
- Roivant Sciences Ltd. ROIV Phase 3 · immunology/inflammation
- Royalty Pharma plc RPRX
S
- SAB Biotherapeutics, Inc. SABS Phase 2 · immunology/inflammation
- Sagimet Biosciences Inc. SGMT Phase 2 · GI/hepatology
- Sana Biotechnology, Inc. SANA Pre-clinical · endocrine/women's health
- Sanofi SNY Phase 3 · immunology/inflammation
- SANUWAVE Health, Inc. SNWV dermatology
- Sarepta Therapeutics, Inc. SRPT Phase 3 · rare genetic
- Satellos Bioscience Inc. MSLE Phase 2 · rare genetic
- Savara Inc SVRA Phase 3 · respiratory
- Scholar Rock Holding Corp SRRK Phase 3 · rare genetic
- Schrodinger, Inc. SDGR Phase 1 · other
- Scienture Holdings, Inc. SCNX Approved · cardio-renal-metabolic
- Scilex Holding Co SCLX Phase 3 · pain/anesthesia
- Scinai Immunotherapeutics Ltd. SCNI Pre-clinical · immunology/inflammation
- SciSparc Ltd. SPRC Phase 2 · CNS/neurology/psychiatry
- Scynexis Inc SCYX Phase 1 · cardio-renal-metabolic
- Seaport Therapeutics, Inc. SPTX Phase 2 · CNS/neurology/psychiatry
- SeaStar Medical Holding Corp ICU cardio-renal-metabolic
- Seismic Therapeutic, Inc. Unknown Phase 1 · cardio-renal-metabolic
- Sellas Life Sciences Group, Inc. SLSN Phase 3 · oncology
- Sensus Healthcare, Inc. SRTS oncology
- Senti Biosciences Holdings, Inc. SNTI Phase 1 · oncology
- Septerna, Inc. SEPN Phase 1 · other
- Seres Therapeutics, Inc. MCRB Phase 1 · infectious disease
- Serina Therapeutics, Inc. SER Phase 1 · CNS/neurology/psychiatry
- Shattuck Labs, Inc. STTK Phase 1 · immunology/inflammation
- Shoulder Innovations, Inc. SI other
- Shuttle Pharmaceuticals Holdings, Inc. SHPH Phase 2 · oncology
- SI-BONE, Inc. SIBN other
- SIGA Technologies, Inc. SIGA Pre-clinical · infectious disease
- Sight Sciences, Inc. SGHT ophthalmology
- Silence Therapeutics plc SLN Phase 2 · hematology
- Silexion Therapeutics Corp SLXN Phase 2 · oncology
- Silo Pharma, Inc. SILO Pre-clinical · CNS/neurology/psychiatry
- Sinovac Biotech Ltd SVA Phase 3 · infectious disease
- Sintx Technologies, Inc. SINT other
- Sionna Therapeutics, Inc. SION Phase 2 · rare genetic
- SkinHealth Systems Inc. SKIN dermatology
- Skye Bioscience, Inc. SKYE Phase 2 · cardio-renal-metabolic
- SL Science Holding Ltd SLBT Pre-clinical · oncology
- Sol-Gel Technologies Ltd. SLGL Phase 3 · dermatology
- Solid Biosciences Inc. SLDB Phase 3 · rare genetic
- Soligenix, Inc. SNGX Phase 2 · dermatology
- Solventum Corp SOLV
- Sonoma Pharmaceuticals, Inc. SNOA dermatology
- Spectral AI, Inc. MDAI dermatology
- Spero Therapeutics, Inc. SPRO Phase 1 · immunology/inflammation
- Spruce Biosciences, Inc. SPRB Phase 2 · rare genetic
- SpyGlass Pharma, Inc. SGP Phase 3 · ophthalmology
- Spyre Therapeutics, Inc. SYRE Phase 2 · immunology/inflammation
- SS Innovations International, Inc. SSII other
- Stevanato Group S.p.A. STVN
- Stoke Therapeutics, Inc. STOK Phase 3 · CNS/neurology/psychiatry
- Structure Therapeutics Inc. GPCR Phase 3 · cardio-renal-metabolic
- Stryker Corp SYK other
- Summit Therapeutics Inc. SMMT Phase 3 · oncology
- Sunshine Biopharma Inc. SBFM Pre-clinical · oncology
- Supernus Pharmaceuticals, Inc. SUPN Phase 2 · CNS/neurology/psychiatry
- Surrozen, Inc. SRZN Pre-clinical · ophthalmology
- Sutro Biopharma, Inc. STRO Phase 1 · oncology
- Syndax Pharmaceuticals Inc SNDX Phase 3 · oncology
T
- Tactile Systems Technology Inc TCMD
- Takeda Pharmaceutical Co Ltd TAK Phase 3 · GI/hepatology
- Talphera, Inc. TLPH Phase 3 · cardio-renal-metabolic
- Tandem Diabetes Care Inc TNDM endocrine/women's health
- Tango Therapeutics, Inc. TNGX Phase 2 · oncology
- Tarsus Pharmaceuticals, Inc. TARS Phase 2 · ophthalmology
- Taysha Gene Therapies, Inc. TSHA Phase 2 · rare genetic
- Tectonic Therapeutic, Inc. TECX Phase 2 · cardio-renal-metabolic
- TELA Bio, Inc. TELA other
- Teleflex Inc TFX
- Telix Pharmaceuticals Ltd TLX Phase 3 · oncology
- Telomir Pharmaceuticals, Inc. TELO Pre-clinical · oncology
- Tempest Therapeutics, Inc. TPST Phase 1 · oncology
- Tenax Therapeutics, Inc. TENX Phase 3 · cardio-renal-metabolic
- Tenaya Therapeutics, Inc. TNYA Phase 1 · cardio-renal-metabolic
- Tenon Medical, Inc. TNON pain/anesthesia
- Teva Pharmaceutical Industries Ltd TEVA Phase 3 · CNS/neurology/psychiatry
- Tevogen Inc. TVGN Phase 1 · infectious disease
- TG Therapeutics, Inc. TGTX Phase 3 · CNS/neurology/psychiatry
- TherapeuticsMD, Inc. TXMD
- Theriva Biologics, Inc. TOVX Phase 2 · oncology
- Tilray Brands, Inc. TLRY
- Tiziana Life Sciences Ltd TLSA Phase 2 · CNS/neurology/psychiatry
- Tonix Pharmaceuticals Holding Corp. TNXP Phase 2 · pain/anesthesia
- Transcode Therapeutics, Inc. RNAZ Phase 1 · oncology
- Travere Therapeutics, Inc. TVTX Phase 3 · cardio-renal-metabolic
- Traws Pharma, Inc. TRAW Phase 2 · infectious disease
- Treace Medical Concepts, Inc. TMCI other
- Trevi Therapeutics, Inc. TRVI Phase 3 · respiratory
- TRex Bio, Inc. TRXB Phase 1 · immunology/inflammation
- Trinity Biotech PLC TRIB endocrine/women's health
- TriSalus Life Sciences, Inc. TLSI Phase 1 · oncology
- Trulieve Cannabis Corp. TRLV
- TScan Therapeutics, Inc. TCRX Phase 3 · oncology
- TuHURA Biosciences, Inc. HURA Phase 3 · oncology
- Turn Therapeutics Inc. TTRX Phase 2 · dermatology
- Tvardi Therapeutics, Inc. TVRD Phase 1 · GI/hepatology
- Tyra Biosciences, Inc. TYRA Phase 2 · oncology
U
- UFP Technologies Inc UFPT
- Ultragenyx Pharmaceutical Inc. RARE Phase 3 · rare genetic
- Unicycive Therapeutics, Inc. UNCY Phase 3 · cardio-renal-metabolic
- uniQure N.V. QURE Phase 2 · CNS/neurology/psychiatry
- United Therapeutics Corporation UTHR Phase 3 · respiratory
- Universe Pharmaceuticals INC UPC
- Unknown Unknown Phase 2 · oncology
- Unknown Unknown Phase 3 · oncology
- Upstream Bio, Inc. UPB Phase 2 · respiratory
- UroGen Pharma Ltd. URGN Phase 3 · oncology
- Usana Health Sciences Inc USNA
- Utah Medical Products Inc UTMD endocrine/women's health
V
- Valion Bio, Inc. VBIO Phase 1 · other
- Valneva SE VALN Phase 3 · infectious disease
- Vanda Pharmaceuticals Inc. VNDA Phase 3 · dermatology
- Vaxcyte, Inc. PCVX Phase 3 · infectious disease
- Vera Therapeutics, Inc. VERA Phase 2 · cardio-renal-metabolic
- Veradermics, Inc MANE Phase 3 · dermatology
- Verastem, Inc. VSTM Phase 2 · oncology
- Veraxa Biotech AG - Post de-SPAC VRXA Phase 1 · oncology
- Vericel Corp VCEL Phase 3 · other
- Verrica Pharmaceuticals Inc. VRCA Phase 3 · dermatology
- Vertex Pharmaceuticals Inc VRTX Phase 3 · cardio-renal-metabolic
- Veru Inc. VERU Phase 2 · cardio-renal-metabolic
- Viatris Inc. VTRS Phase 3 · other
- Vicore Pharma Holding AB VCRE Phase 2 · respiratory
- Viking Therapeutics, Inc. VKTX Phase 3 · cardio-renal-metabolic
- Vir Biotechnology, Inc. VIR Phase 3 · infectious disease
- Virax Biolabs Group Ltd VRAX infectious disease
- Viridian Therapeutics, Inc.\ VRDN Phase 3 · ophthalmology
- Vistagen Therapeutics, Inc. VTGN Phase 3 · CNS/neurology/psychiatry
- Vivos Therapeutics, Inc. VVOS respiratory
- VivoSim Labs, INC. VIVS Phase 2
- Vogenx, Inc. VOGX Phase 2 · endocrine/women's health
- Vor Biopharma Inc. VOR Phase 3 · immunology/inflammation
- Voyager Therapeutics, Inc. VYGR Phase 1 · CNS/neurology/psychiatry
- vTv Therapeutics Inc. VTVT Phase 3 · cardio-renal-metabolic
- Vyome Holdings, Inc. HIND Phase 2 · dermatology
W
- Wave Life Sciences, Inc. WVE Phase 2 · cardio-renal-metabolic
- Werewolf Therapeutics, Inc. HOWL Phase 1 · oncology
- West Pharmaceutical Services Inc WST
- Whitehawk Therapeutics, Inc. WHWK Phase 1 · oncology
- WORK Medical Technology Group LTD WOK other
X
- X4 Pharmaceuticals, Inc XFOR Phase 3 · hematology
- XBiotech Inc. XBIT Phase 2 · oncology
- Xencor, Inc. XNCR Phase 3 · oncology
- Xenetic Biosciences, Inc. XBIO Pre-clinical · oncology
- Xenon Pharmaceuticals Inc. XENE Phase 3 · CNS/neurology/psychiatry
- Xeris Biopharma Holdings, Inc. XERS Phase 2 · endocrine/women's health
- Xilio Therapeutics, Inc. XLO Phase 2 · oncology
- XORTX Therapeutics Inc. XRTX Phase 2 · cardio-renal-metabolic
- Xtant Medical Holdings, Inc. XTNT other
- XTL Biopharmaceuticals Ltd XTLB Pre-clinical · CNS/neurology/psychiatry
Y
- Yarrow Bioscience, Inc. YARW Phase 1 · endocrine/women's health
- YD Bio Ltd YDES Pre-clinical · oncology
Z
- Zai Lab Ltd ZLAB Phase 3 · oncology
- Zenas BioPharma, Inc. ZBIO Phase 3 · immunology/inflammation
- Zentalis Pharmaceuticals, Inc. ZNTL Phase 3 · oncology
- Zevra Therapeutics, Inc. ZVRA Phase 3 · rare genetic
- Zhengye Biotechnology Holding Ltd ZYBT infectious disease
- Zoetis Inc. ZTS other
- Zura Bio Ltd ZURA Phase 2 · immunology/inflammation
- Zymeworks Inc. ZYME Phase 1 · oncology
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.